Dr. Salim Rezaie of REBEL Cast interviews Dr. Chernaik about COVID-19, Thrombosis, and Anticoagulation
Early reports have shown that COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute VTE and exactly how to treat it is an evolving area. Limited data suggest pulmonary microvascular thrombosis may play a role in progressive respiratory failure. However, most evidence is limited to small retrospective trials. As we wait for more evidence, clinical decisions have to made at the bedside and decisions about pharmacological prophylaxis are starting to emerge. In this episode I sit down with a special guest that is new to REBEL Cast to talk about the dilemmas involving COVID-19 and thrombosis.
Guest:
Andrew Chernaik, M.D.
Hospitalist, New West Physicians
Golden, Colorado
Education Undergraduate Education Arts and History – Tulane University, New Orleans Medical Education Doctor of Medicine – St. George’s University School of Medicine, Grenada, West Indies Residency Internal Medicine – Medical College of Pennsylvania, Philadelphia, PA Fellowship Intensive Care Registrar – St. Vincent’s Hospital, Melbourne, Australia.
Listen to the MP3 of REBEL Cast Episode 81
Tags: Anticoagulation, awareness, COVID-19, COVID-19 Virus, Thrombosis